How Spain became the preferred laboratory for multinationals—and why this leadership does not yet translate into industrial power. By Ehab Soltan HoyLunes – Europe is undergoing a silent redefinition of its pharmaceutical ecosystem. The regulatory reform driven by the European Commission, the progressive application of the European Health Technology Assessment (HTA) Regulation, and the consolidation of the scientific…
Read MoreThe Unexpected “Hub”: Geopolitics of Clinical Innovation in the New European Architecture
